Sankyo’s suffers patent setback in Japan
Pravastatin is marketed by Bristol-Myers Squibb in the US under the name Pravachol. The ruling in Teva’s favour is the second decision regarding this product that has been
Japan-based Ono Pharmaceutical has signed an agreement with US biotechnology company Aitia to collaborate on drug discovery in neurological diseases.